Previous studies reported that upregulation of ALDOA is correlated with poor prognosis in colorectal cancer (Dai et al., 2018), gastric cancer (Jiang et al., 2018), and hepatocellular carcinoma (Tang et al., 2021). The gene discussed is ALDOA; the disease is hepatocellular carcinoma.